cricket and cave: cetuximab for the treatment of mcrc
Published 2 years ago • 283 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:53
pooled analysis from the cricket and cave trials for the treatment of mcrc
-
4:25
fire-4.5: folfoxiri plus either bevacizumab or cetuximab in mcrc
-
3:01
deeper: m-folfoxiri and cetuximab versus bevacizumab in mcrc
-
2:11
fire-4: evaluation of 1l efficacy of folfiri/cetuximab in patients with ras-wt mcrc
-
5:44
a phase i/ii investigating the addition of io to the standard of care for patients with mss mcrc
-
1:45
breakwater: encorafenib plus cetuximab in patients with braf v600e-mutant mcrc
-
15:42
ct of urinary pathology 2 | free radiology cme
-
29:01
tumor imaging: ct colonography - course sample
-
26:20
colorectal cancer: the link between the immune microenvironment and outcomes
-
10:26
cetuximab or chemotherapy in hnscc?
-
0:33
cetuximab - erbitux - in a nutshell.
-
1:04
deeper: folfoxiri cetuximab or bevacizumab for 1l mcrc
-
2:45
1l folfoxiri plus cetuximab or bevacizumab for ras wild-type mcrc
-
1:49
fire-6: avelumab folfiri plus cetuximab followed by avelumab maintenance in untreated raswt mcrc
-
2:00
ermes: folfiri/cetuximab followed by cetuximab inferior to soc in ras & braf wt mcrc
-
1:08
dr. weinberg on the role of cetuximab in metastatic crc
-
4:31
cetuximab and chemoradiation
-
5:04
beacon: encorafenib plus cetuximab with or without binimetinib for braf v600e–mutant metastatic ...
-
6:47
cancer: cetuximab (erbitux)
-
8:37
cetuximab with xelox or xeliri is tolerable and effective in ras wild-type mcrc
-
2:23
swog s2107: encorafenib, cetuximab ± nivolumab in previously treated, mss, brafv600e crc
-
4:28
introduction: bevacizumab versus cetuximab in metastatic colorectal cancer